The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Ganesh Manoharan

Showing 1-8 of 8 articles
Interventions for valvular disease
Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study
Manoharan G, Grube E, Van Mieghem N, Brecker S, Fiorina C, Kornowski R, Danenberg H, Ruge H, Thiele H, Lancellotti P, Søndergaard L, Tamburino C, Oh J, Fan Y, Windecker S
November 20, 2020 | 10.4244/EIJ-D-20-00279
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Coronary interventions
Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program
Manoharan G, Belardi J, Du Z, Lee M, Qiao S, Serruys P, Windecker S, Xu B, Yeung A
January 20, 2017 | 10.4244/EIJ-D-16-00079
Interventions for valvular disease
TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery
van Gils L, Tchétché D, Latib A, Sgroi C, Manoharan G, Möllmann H, Van Mieghem N
September 18, 2016 | 10.4244/EIJV12SYA6
Interventions for valvular disease
Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system
Manoharan G, Linke A, Möllmann H, Redwood S, Frerker C, Kovac J, Walther T
August 20, 2016 | 10.4244/EIJV12I6A125
First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve
Jeger R, Manoharan G, Kaiser C
March 20, 2014 | 10.4244/EIJV9I11A229
St Jude Medical Portico valve
Manoharan G, Spence M, Rodés-Cabau J, Webb J
September 30, 2012 | 10.4244/EIJV8SQA18
Complications of transcatheter aortic valve implantation: avoidance and management
Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, MacCarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N
September 30, 2011 | 10.4244/EIJV7I5A99

Latest news

AHEAD OF PRINT
Three-year TAVI outcomes for BAV vs TAV
FREE ARTICLE - Dao Zhou et al.
January 20, 2022
AHEAD OF PRINT
Percutaneous management of left ventricular assist device outflow graft obstruction
FREE ARTICLE - Aleksandra Gasecka et al.
January 19, 2022
NEW ISSUE
EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…
December 17, 2021
AHEAD OF PRINT
Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients
FREE ARTICLE - Rebecca Torguson et al.
January 17, 2022
AHEAD OF PRINT
Redo transcatheter mitral valve replacement in mitral annular calcification
FREE ARTICLE - Jennifer Jdaidani et al
January 13, 2022
AHEAD OF PRINT
TAVI vs SAVR in bicuspid aortic valve stenosis
FREE ARTICLE - Monil Majmundar et al.
January 12, 2022
AHEAD OF PRINT
Management of MR patients undergoing TMVI screening
FREE ARTICLE - Sebastian Ludwig et al.
January 7, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke